Department of Biomedicine, University of Basel, 4031 Basel, Switzerland.
Sci Transl Med. 2014 Apr 16;6(232):232fs16. doi: 10.1126/scitranslmed.3008558.
Along with scientific and regulatory issues, the translation of cell and tissue therapies in the routine clinical practice needs to address standardization and cost-effectiveness through the definition of suitable manufacturing paradigms.
除了科学和监管问题,细胞和组织疗法的常规临床应用还需要通过定义合适的制造模式来解决标准化和成本效益问题。